Saturday, December 20, 2014

I.P.O. of Juno Therapeutics, Developer of a Cancer Treatment, Excites Investors

… Dendreon, a company with a prostate cancer therapy that similarly required processing … beyond blood cancers to the solid tumors like lung, breast and prostate cancers, which constitute a majority of cancer

No comments:

Post a Comment